BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35023197)

  • 21. Characterization of KIR + NKG2A + Eomes- NK-like CD8+ T cells and their decline with age in healthy individuals.
    Kasakovski D; Zeng X; Lai J; Yu Z; Yao D; Chen S; Zha X; Li Y; Xu L
    Cytometry B Clin Cytom; 2021 Jul; 100(4):467-475. PubMed ID: 32830898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stage-Specific Requirement for Eomes in Mature NK Cell Homeostasis and Cytotoxicity.
    Wagner JA; Wong P; Schappe T; Berrien-Elliott MM; Cubitt C; Jaeger N; Lee M; Keppel CR; Marin ND; Foltz JA; Marsala L; Neal CC; Sullivan RP; Schneider SE; Keppel MP; Saucier N; Cooper MA; Fehniger TA
    Cell Rep; 2020 Jun; 31(9):107720. PubMed ID: 32492428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Role of transcription factor T-bet and Eomes in IFN-gamma secretion of different human T cell subsets].
    Wang HT; Ge XS; Xue ZP; Li BQ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jan; 26(1):31-4. PubMed ID: 20056084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cutting Edge: Eomesodermin Is Sufficient To Direct Type 1 Innate Lymphocyte Development into the Conventional NK Lineage.
    Pikovskaya O; Chaix J; Rothman NJ; Collins A; Chen YH; Scipioni AM; Vivier E; Reiner SL
    J Immunol; 2016 Feb; 196(4):1449-54. PubMed ID: 26792802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T-bet and Eomesodermin in NK Cell Development, Maturation, and Function.
    Simonetta F; Pradier A; Roosnek E
    Front Immunol; 2016; 7():241. PubMed ID: 27379101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NK cells inhibit T-bet-deficient, autoreactive Th17 cells.
    Wu W; Shi S; Ljunggren HG; Cava AL; Van Kaer L; Shi FD; Liu R
    Scand J Immunol; 2012 Dec; 76(6):559-66. PubMed ID: 22928727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxygen tension regulates NK cells differentiation from hematopoietic stem cells in vitro.
    Yun S; Lee SH; Yoon SR; Myung PK; Choi I
    Immunol Lett; 2011 Jun; 137(1-2):70-7. PubMed ID: 21354208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Phenotypic and Functional Characteristics Between Canine Non-B, Non-T Natural Killer Lymphocytes and CD3
    Lee SH; Shin DJ; Kim Y; Kim CJ; Lee JJ; Yoon MS; Uong TNT; Yu D; Jung JY; Cho D; Jung BG; Kim SK; Suh GH
    Front Immunol; 2018; 9():841. PubMed ID: 29755462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eomesodermin and T-bet mark developmentally distinct human natural killer cells.
    Collins A; Rothman N; Liu K; Reiner SL
    JCI Insight; 2017 Mar; 2(5):e90063. PubMed ID: 28289707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a Porcine Liver Eomes
    De Pelsmaeker S; Denaeghel S; Hermans L; Favoreel HW
    Front Immunol; 2019; 10():2561. PubMed ID: 31736976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Active STAT5 regulates T-bet and eomesodermin expression in CD8 T cells and imprints a T-bet-dependent Tc1 program with repressed IL-6/TGF-β1 signaling.
    Grange M; Verdeil G; Arnoux F; Griffon A; Spicuglia S; Maurizio J; Buferne M; Schmitt-Verhulst AM; Auphan-Anezin N
    J Immunol; 2013 Oct; 191(7):3712-24. PubMed ID: 24006458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression Regulation and Function of T-Bet in NK Cells.
    Huang C; Bi J
    Front Immunol; 2021; 12():761920. PubMed ID: 34675939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential localization of T-bet and Eomes in CD8 T cell memory populations.
    McLane LM; Banerjee PP; Cosma GL; Makedonas G; Wherry EJ; Orange JS; Betts MR
    J Immunol; 2013 Apr; 190(7):3207-15. PubMed ID: 23455505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CXCR6
    Angelo LS; Bimler LH; Nikzad R; Aviles-Padilla K; Paust S
    Front Immunol; 2019; 10():469. PubMed ID: 30941128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CXCR6 marks a novel subset of T-bet(lo)Eomes(hi) natural killer cells residing in human liver.
    Stegmann KA; Robertson F; Hansi N; Gill U; Pallant C; Christophides T; Pallett LJ; Peppa D; Dunn C; Fusai G; Male V; Davidson BR; Kennedy P; Maini MK
    Sci Rep; 2016 May; 6():26157. PubMed ID: 27210614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IRF4 Regulates the Ratio of T-Bet to Eomesodermin in CD8+ T Cells Responding to Persistent LCMV Infection.
    Nayar R; Schutten E; Jangalwe S; Durost PA; Kenney LL; Conley JM; Daniels K; Brehm MA; Welsh RM; Berg LJ
    PLoS One; 2015; 10(12):e0144826. PubMed ID: 26714260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infection history determines the differentiation state of human CD8+ T cells.
    van Aalderen MC; Remmerswaal EB; Verstegen NJ; Hombrink P; ten Brinke A; Pircher H; Kootstra NA; ten Berge IJ; van Lier RA
    J Virol; 2015 May; 89(9):5110-23. PubMed ID: 25717102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Cytomegalovirus (CMV) and Ageing on T-Bet and Eomes Expression on T-Cell Subsets.
    Hassouneh F; Lopez-Sejas N; Campos C; Sanchez-Correa B; Tarazona R; Pera A; Solana R
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28661443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T-BET drives the conversion of human type 3 innate lymphoid cells into functional NK cells.
    Kiekens L; Wahlen S; Persyn E; De Vos Z; Taghon T; Vandekerckhove B; Leclercq G
    Front Immunol; 2022; 13():975778. PubMed ID: 36330517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional control of human T-BET expression: the role of Sp1.
    Yu J; Wei M; Boyd Z; Lehmann EB; Trotta R; Mao H; Liu S; Becknell B; Jaung MS; Jarjoura D; Marcucci G; Wu LC; Caligiuri MA
    Eur J Immunol; 2007 Sep; 37(9):2549-61. PubMed ID: 17705132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.